ReviewBiomedicines2022
SGLT2 Inhibitors in Chronic Kidney Disease: From Mechanisms to Clinical Practice.
Roko Skrabic et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this paperpooled itcites it
ReviewBiomedicines2022
Roko Skrabic et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.